Clinical trial
Traditional Chinese Medicine or Low-dose Dexamethasone in Symptomatic Patients With Post-COVID-19 Parenchymal Lung Abnormalities: a Randomized Controlled Trial Three Arm, Parallel Group, Single Blind, Randomized Controlled Trial.
NCT05798195 is registered in ClinicalTrials.gov with China-Japan Friendship Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Traditional Chinese Medicine or Low-dose Dexamethasone in Symptomatic Patients With Post-COVID-19 Parenchymal Lung Abnormalities: a Randomized Controlled Trial Three Arm, Parallel Group, Single Blind, Randomized Controlled Trial.
- Lead sponsor
- China-Japan Friendship Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2023
- Completion date
- December 31, 2024
- Enrollment
- 420 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 pneumonia